SARS-CoV-2 antibody test in connection with a short questionnaire (especially regarding field of work, prior tests, prior illness and prior symptoms).
Study Overview
Study name | SLKovid Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19) |
Project | SLKovid |
Sources of Monetary or Material Support | Private sponsorship, Institutional budget |
Region(s) | Germany |
Location(s) | Heilbronn |
Primary outcome | Serum analyses of antibodies against SARS-CoV-2 at 0 (if positive, additionalley at 3, 6 and 12 months) plus questionnaire |
Secondary outcome | [Characterisation of the immune answer to SARS-CoV-2 Comparison of several commercially available CE-certified test Systems Confirmation by neutralisation test Analysis of infection rate by exposition and field of work Evaluation of risk factors and prevention factors] |
Study population N | 3000 |
Total population in the area | 125960 |
Principal Investigator | Uwe Martens , SLK Kliniken , dilyana.vladimirova@slk-kliniken.de |
Team members |
|
Period | 2020-07-01 till 2020-12-31 |
Study start | 2020-07-01 |
First results expected | 2020-12-31 |
Study metadata
{
"abbreviation": "SLKovid",
"draft": false,
"iscjklanguage": false,
"lastmod": "2021-02-25T11:00:18+01:00",
"recruitment": {
"country": [
"Germany"
],
"group": "general population",
"location": [
{
"latitude": 49.1427,
"longitude": 9.2109,
"place_name": "Heilbronn"
}
],
"type": "monocenter diagnostic trial"
},
"study_dates": {
"sample_end": "2020-12-31",
"sample_start": "2020-07-01",
"study_first_results": "2020-12-31",
"study_start": "2020-07-01"
},
"study_info": {
"funding_sources": "Private sponsorship, Institutional budget",
"primary_outcomes": "Serum analyses of antibodies against SARS-CoV-2 at 0 (if positive, additionalley at 3, 6 and 12 months) plus questionnaire",
"secondary_outcomes": [
"Characterisation of the immune answer to SARS-CoV-2",
"Comparison of several commercially available CE-certified test Systems",
"Confirmation by neutralisation test",
"Analysis of infection rate by exposition and field of work",
"Evaluation of risk factors and prevention factors"
]
},
"study_numbers": {
"population": 125960,
"study_population": 3000
},
"study_pi": {
"email": "dilyana.vladimirova@slk-kliniken.de",
"institution": "SLK Kliniken",
"name": "Uwe Martens",
"role": "Professor"
},
"team": [
{
"institution": "SLK Kliniken",
"name": "Uwe Martens",
"position": "Head of Department for Haematology, Oncology \u0026 Palliative care",
"role": "Principal Investigator",
"title": "Prof. Dr. med."
},
{
"institution": "SLK Kliniken",
"name": "Dilyana Vladimirova",
"position": "Lead of Scientific Queries",
"role": "Scientific Officer",
"title": "PhD"
}
],
"title": "SLKovid Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19)"
}